
Keywords: 5FU; 5-fluorouracil; A; anthracycline; BEACON; BrEAst Cancer Outcomes with NKTR-102; BRCA; breast cancer gene; CALGB; cancer and leukemia Group B; CTCs; circulating tumor cells; CI; confidence interval; CHF; congestive heart failure; DFI; disease-free int